Newsfeeds - Spark Newswire

1 minute read

Delcath Systems: Q2 Earnings Insights

Today, 5:53 PM

Shares of Delcath Systems (NASDAQ:DCTH) fell 13.6% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 49.47% over the past year to ($0.96), which beat the estimate of ($0.99).

DCTH

10 minute read

Earnings Scheduled For August 10, 2021

By Benzinga Insights

Today, 5:53 PM

Companies Reporting Before The Bell • Nautilus Biotechnology (NASDAQ:NAUT) is expected to report earnings for its second quarter.

ABST

2 minute read

Earnings

Earnings Preview For Delcath Systems

By Benzinga Insights

Today, 5:53 PM

Delcath Systems (NASDAQ:DCTH) announces its next round of earnings this Tuesday, August 10. Here is Benzinga's everything-that-matters guide for this Tuesday's Q2 earnings announcement.

DCTH

20 minute read

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights

Today, 5:53 PM

Stocks That Hit 52-Week Lows On Monday Monday morning, 285 companies reached new 52-week lows.

AAU

2 minute read

Movers

12 Health Care Stocks Moving In Friday’s After-Market Session

By Benzinga Insights

Today, 5:53 PM

Gainers Delcath Systems (NASDAQ:DCTH) stock increased by 8.87% to $11.9 during Friday's after-market session. This security traded at a volume of 379 shares come close, making up 0.45% of its average volume over the last 100 days. The company's market cap stands at $87.4 million.

ASLN

1 minute read

News

Return On Capital Employed Overview: Delcath Systems

By Benzinga Insights

Today, 5:53 PM

Delcath Systems (NASDAQ:DCTH) reported Q1 sales of $388.00 thousand. Earnings fell to a loss of $6.85 million, resulting in a 8.25% decrease from last quarter. In Q4, Delcath Systems brought in $507.00 thousand in sales but lost $7.47 million in earnings.

DCTH

2 minute read

News

5 Value Stocks To Watch In The Healthcare Sector

By Benzinga Insights

Today, 5:53 PM

What Defines a Value Stock?

BIO

7 minute read

The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes

By Shanthi Rexaline

Today, 5:53 PM

After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-specific news flow dictated stock moves during the week.

ADAP

1 minute read

Uncategorized

Delcath Systems: Q1 Earnings Insights

By Benzinga Insights

Today, 5:53 PM

Shares of Delcath Systems (NASDAQ:DCTH) were unchanged after the company reported Q1 results. Quarterly Results Earnings per share rose 99.04% over the past year to ($1.04), which missed the estimate of ($0.98).

DCTH